Choon Kim
Gastroenterology · Westminster, MDNPI 1245398874
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 315 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 40.7% of the total. 2023 is the largest year on record at $1,578, 2.6 times the $609 reported in 2019.
Across 315 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Bristol Myers Squibb$430
- Nestle Healthcare Nutrition Inc.$419
- Johnson & Johnson$259
- Gilead$243
- Intercept Pharmaceuticals, Inc.$239
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,934100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 136 | $2,011 |
| Bristol Myers Squibb | 24 | $430 |
| Nestle Healthcare Nutrition Inc. | 34 | $419 |
| Johnson & Johnson | 17 | $259 |
| Gilead | 14 | $243 |
| Intercept Pharmaceuticals, Inc. | 14 | $239 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $222 |
| Merck | 12 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $144 |
| Pfizer | 7 | $122 |
| Sanofi | 4 | $105 |
| Braintree Laboratories, Inc. | 6 | $105 |
| Ferring Pharmaceuticals Inc. | 6 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $68 |
| Redhill Biopharma Inc. | 3 | $47 |
| UCB, Inc. | 2 | $42 |
| Fresenius Kabi USA, LLC | 2 | $37 |
| Ironwood Pharmaceuticals, Inc | 2 | $27 |
| QOL Medical, LLC | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Boston Scientific | 1 | $12 |
How this compares
$4,944 in reported general payments places this provider in the 65th percentile of 455 gastroenterology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 130 | $2,762 |
| Omeprazole | 91 | $1,562 |
| Sulfasalazine | 26 | $1,133 |
| Esomeprazole Magnesium | 14 | $925 |
| Pantoprazole Sodium | 38 | $920 |
| Dicyclomine Hcl | 13 | $388 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Westminster
- Apurva ModiRockville$1.1M
- Sergey KantsevoyBaltimore$1.1M
- Anurag MaheshwariBaltimore$803K
- Aline Charabaty PishvaianBaltimore$631K
- Zachary BormanChevy Chase$520K
- Mouen KhashabBaltimore$440K
- Erica CohenChevy Chase$385K
- Natarajan RavendhranCatonsville$367K
- Raymond CrossBaltimore$341K
- Raja TaunkAnnapolis$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.